Effect of Aspirin on on maternal and fetal factors

Comparison of the effect of 80 and 150 mg aspirin on maternal and fetal factors in first trimester of pregnancy in women who is high risk for preeclampsia in patients referred to teaching hospitals of Shiraz University of Medical Sciences

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140317017035N7

Enrollment

100

Registered

2020-11-28

Start date

2020-12-10

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe preeclampsia. Pre-eclampsia

Interventions

Intervention 1: Intervention group: 50 person will receive 80 mg aspirin untill 34 weeks. Intervention 2: Intervention group: 50 person will receive 150 mg aspirin untill 34 weeks.

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: The singleton pregnant women who are high risk for uteroplacental preeclamsia and GDM based on increased uterine artery resistant on first trimester doppler ultarasonography.

Exclusion criteria

Exclusion criteria: Multiple pregnancy Fetal aneuploidy Fetal anomaly Coagulation disorder Allergy to aspirin Women who use aspirin or heparin before starting study

Design outcomes

Primary

Measure	Time frame
Decrease fetal mortality and morbidity due to preeclampsia. Timepoint: ?After birth. Method of measurement: Vital Signs.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSydeh Fateme Khaleghi

Shiraz University of Medical Sciences

alifatijoon1396@gmail.com+98 71 3233 2365

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026